InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.54%
)
US TECH 100
18,982.40
(
-0.16%
)
Dow Jones
41,393.78
(
0.72%
)
Brent Oil
71.40
(
0.01%
)
Bitcoin
58,768.61
(
-0.69%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Gold Seeker

Send PM Follow Ignore
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Gold Seeker

Re: opportunityknocking post# 21269

Sunday, 08/02/2009 12:20:15 AM

Sunday, August 02, 2009 12:20:15 AM

Post# of 30387
In April 2008 Biocurex and Abbott amended the license agreement. The amendment relieves Abbott of future obligations to perform further research and development with respect to the RECAF technology as well as the obligation to pay annual minimum royalties.

Since you are big on lawyers saving RECAF, why don't you ask a lawyer to sue Abbott for the above.

Abbott has no further obligations to perform research and development with respect to the RECAF technology as well as the obligation to pay annual minimum royalties.

It cannot be stated any clearer than that. Let's just carry that malpractice a step further. Sic those lawyers on em!
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up